Tofacitinib is a useful option for the treatment of parents with RA.
Effective treatment of chronic plaque psoriasis.
Tofactinib demonstrated consistent safety and persistent efficacy over 48 months in parents with RA.
Works by blocking the body’s production of enzymes called Janus Kinases (Jak’s) JAK’s play a role in joint inflammation in RA, which can cause pain, swelling and stiffeness.